Skip to content

A study to evaluate the effect of dexmedetomidine for general anaesthesia considering the weight of the patient

A prospective randomised comparative study to evaluate the effect of dexmedetomidine based on total body weight and ideal body weight.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/013885
Enrollment
100
Registered
2018-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA I & II patients, between age group18-60yrs with BMI of 30kg/m2 and above, undergoing elective laparoscopic surgery under general anaesthesia for atleast 30 minutes and maximum of 3 hours

Interventions

Intervention1: Intravenous dexmedetomidine: Intravenous dexmedetomidine calculated as per the Ideal Body weight as a bolus dose of 1microgram/kg prior to induction of anaesthesia followed by infusio

Sponsors

Dr L H Hiranandani Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients undergoing elective laparoscopic surgery 2 With BMI between 30kg/m2 and above 3 ASA 1and 2 under general anaesthesia 4 Duration of 30 minutes to maximum of 3 hours 5 Informed consent

Exclusion criteria

Exclusion criteria: 1.History of significant cardiac pulmonary, liver or renal disease. 2. Patient scheduled for awake bronchoscopic intubation. 3. Previous history of cerebrovascular accident, other neurological disorders and those on long term drugs affecting CNS (chronic BZDâ??s/ opioids) 4. Allergy to dexmedetomidine . 5. Patients with significant hemodynamic changes intraoperatively, fall of Mean arterial blood pressure by more than 20% of baseline, 6. Intraoperative entropy of more than 60 for more than 10 minutes

Design outcomes

Primary

MeasureTime frame
The ideal weight scalar for assessing dose of intravenous dexmedetomidine for the haemodynamic stability during general anaesthesia during the duration of laprascopic surgeryTimepoint: Intraoperatively during surgery

Secondary

MeasureTime frame
Recovery parameters like 1 Sedation score post extubation 2 Time for extubation after stoping dexmedetomidine infusion 3. Time for eye opening after stopping dexmedetomidine infusion 4. Time for obeying oral commands after stopping dexmedetomidine infusion 5. Time to achieve entropy values more than 90 after stopping dexmedetomidine infusion 6. Consumption of sevoflurane at the end of surgeryTimepoint: 1. Sedation score - post extubation 2. Time for extubation - time required after stopping dexmedetomidine infusion to the time of extubation 3. Time for eye opening after stopping dexmedetomidine infusion to the time of extubation 4. Time for obeying oral commands after stopping dexmedetomidine infusion to the time of extubation 5. Time taken to achieve entropy values more than 90 after stopping dexmedetomidine infusion 6. Consumption of sevoflurane at the end of surgery

Countries

India

Contacts

Public ContactDr Meenoti Potdar

Dr L H Hiranandani Hospital

meenoti@gmail.com9920627839

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026